Prospective clinical cohort study: low incidence of Barrett esophagus but high rate of reflux disease at 5-year follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass

Background: Gastroesophageal reflux disease seems more frequent after laparoscopic sleeve gas-trectomy (LSG) than Roux-en-Y gastric bypass (LRYGB). Retrospective case series have raised con-cerns about a high incidence of Barrett esophagus (BE) after LSG.Objective: This prospective clinical cohort study compared the incidence of BE >5 years after LSG and LRYGB.Setting: St. Clara Hospital, Basel, and University Hospital, Zueurorich, Switzerland.Methods: Patients were recruited from 2 bariatric centers where preoperative gastroscopy is stan-dard practice and LRYGB is preferred for patients with preexisting gastroesophageal reflux disease. At follow-up & GE;5 years after surgery, patients underwent gastroscopy with quadrantic biopsies from the squamocolumnar junction and metaplastic segment. Symptoms were assessed using validated questionnaires. Wireless pH measurement assessed esophageal acid exposure.Results: A total of 169 patients were included, with a median 7.0 6 1.5 years after surgery. In the LSG group (n = 83), 3 patients had endoscopically and histologically confirmed de novo BE; in the LRYGB group (n = 86), there were 2 patients with BE, 1 de novo and 1 preexisting (de novo BE, 3.6% versus 1.2%; P = .362). At follow-up, reflux symptoms were reported more frequently by the LSG group than by the LRYGB group (51.9% versus 10.5%). Similarly, moderate-to-severe reflux esophagitis (Los Angeles grade B-D) was more common (27.7% versus 5.8%) despite greater use of proton pump inhibitors (49.4% versus 19.7%), and pathologic acid exposure was more frequent in patients who underwent LSG than in patients who underwent LRYGB.Conclusions: After at least 5 years of follow-up, a higher incidence of reflux symptoms, reflux esophagitis, and pathologic esophageal acid exposure was found in patients who underwent LSG compared with patients who underwent LRYGB. However, the incidence of BE after LSG was low and not significantly different between the 2 groups. (Surg Obes Relat Dis 2023;19:707- 716.) & COPY; 2023 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).